Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients

Autor: Julia Funovits, Josef S Smolen, Daniel Baker, Marcus D Köller, Aileen Pangan, Daniel Aletaha

Publikováno v: Rheumatology. 48:1575-1580

Objective. To compare the efficacy of MTX and MTXþTNF inhibitors (TNFis) in elderly patients with RA with that in patients of younger age. Methods. Data from two large, randomized, controlled, double-blind trials in patients with early RA using adal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865b613feabdc33470da5e5293dbe82b
https://doi.org/10.1093/rheumatology/kep291

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

Autor: Jeffrey Siegel, Daniel Aletaha, Kaleb Michaud, Vibeke Strand, Tore K Kvien, Josef S Smolen, Marco Matucci-Cerinic, Theodore Pincus, Andrew K Brown, Paul Emery, Pamela Montie, Lilian H D van Tuyl, Juan J. Gomez-Reino, Frederick Wolfe, Barbara White, David T. Felson, George A. Wells, S. M. M. Verstappen, Gillian A. Hawker, Dinesh Khanna, Tuulikki Sokka, Maarten Boers, Cornelia F Allaart, Angela Zink, Joan M. Bathon, Maxime Dougados, Emilio Martín-Mola, Stefano Bombardieri, Alan Tyndall, Joachim Listing, Lee S. Simon, Edward C. Keystone, Daniel E. Furst, Bi Zhang, John R. Kirwan, Peter Tugwell, Désirée van der Heijde, Julia Funovits, Peter Brooks, Maarten de Wit, Bernard Combe, Robert Landewé, Hyon K. Choi, Pamela Richards

Publikováno v: Annals of the Rheumatic Diseases, 70(3), 404-413. BMJ Publishing Group
Felson, D T, Smolen, J S, Wells, G, Zhang, B, van Tuyl, H D, Funovits, J, Aletaha, D, Allaart, C F, Bathon, J, Bombardieri, S, Brooks, P, Brown, A, Matucci-Cerinic, M, Choi, H, Combe, B, de Wit, M, Dougados, M, Emery, P, Furst, D, Gomez-Reino, J, Hawker, G, Keystone, E, Khanna, D, Kirwan, J, Kvien, T K, Landewe, R, Listing, J, Michaud, K, Martin-Mola, E, Montie, P, Pincus, T, Richards, P, Siegel, J N, Simon, L S, Sokka, T, Strand, V, Tugwell, P, Tyndall, A, van der Heijde, D, Verstappen, S, White, B, Wolfe, F, Zink, A & Boers, M 2011, ' American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials ', Arthritis & Rheumatism, vol. 63, no. 3, pp. 573-586 . https://doi.org/10.1002/art.30129
Arthritis and rheumatism, 63(3), 573-586. John Wiley and Sons Inc.
Annals of the rheumatic diseases, 70(3), 404-413. BMJ Publishing Group
Felson, D T, Smolen, J S, Wells, G, Zhang, B, van Tuyl, L H D, Funovits, J, Aletaha, D, Allaart, C F, Bathon, J, Bombardieri, S, Brooks, P, Brown, A, Matucci-Cerinic, M, Choi, H, Combe, B, de Wit, M, Dougados, M, Emery, P, Furst, D, Gomez-Reino, J, Hawker, G, Keystone, E, Khanna, D, Kirwan, J, Kvien, T K, Landewe, R, Listing, J, Michaud, K, Martin-Mola, E, Montie, P, Pincus, T, Richards, P, Siegel, J N, Simon, L S, Sokka, T, Strand, V, Tugwell, P, Tyndall, A, van der Heijde, D, Verstappen, S, White, B, Wolfe, F, Zink, A & Boers, M 2011, ' American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials ', Arthritis Care and Research, vol. 63, no. 3, pp. 573-586 . https://doi.org/10.1002/art.30129
Annals of the Rheumatic Diseases, 70(3), 404-413
Arthritis and Rheumatism, 63(3), 573-586
Arthritis & Rheumatism, 63(3), 573-586. Wiley
Arthritis & Rheumatism, 63(3), 573-586. John Wiley and Sons Inc.

ObjectiveRemission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there is no widely used definition of remission that is stringent but achievable and could be applied uniformly as an outcome measure in clinical trials. This wor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f704e278da85616a1044722a2a4a14c
https://cris.maastrichtuniversity.nl/en/publications/0ee8182a-2617-491f-8512-4adf90a4af38

Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis

Autor: Arthur Kavanaugh, Josef S. Smolen, Julia Funovits, Daniel Baker, Monika Schoels, Daniel Aletaha

Publikováno v: Annals of the rheumatic diseases. 69(8)

Background and objectives Instruments for measuring disease activity in psoriatic arthritis (PsA) are not yet firmly established, and most of the currently employed ones have been derived for rheumatoid arthritis. Some of these instruments are based

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63130124bd7a1722a207520947ab6a0
https://pubmed.ncbi.nlm.nih.gov/20525844

Perception of improvement in patients with rheumatoid arthritis varies with disease activity levels at baseline

Autor: M. M. Ward, Daniel Aletaha, T.K. Kvien, Julia Funovits, Josef S Smolen

Publikováno v: Arthritis and rheumatism. 61(3)

Objective To analyze the minimum clinically important improvement (MCII) of disease activity measures in rheumatoid arthritis (RA) using patient-derived anchors, and to assess whether criteria for improvement differ with baseline disease activity. Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a366651ce386fc5d87ff923e9abfe96b
https://pubmed.ncbi.nlm.nih.gov/19248136